Health & Science

In the last week of June, some 6,000 people in the United States were hospitalized for COVID. In the last week of July, that number had climbed to 9,000.

More than a million U.S. workers over 60 years old lost their jobs during the pandemic. Most furloughed workers went back to work, but older adults are getting left behind.

At the dawn of what some are calling a fourth industrial revolution powered by artificial intelligence, what are the limitations when it comes to fixing a pipe?

For the first time on record, the firearm suicide rate for Black teens is higher than for white teens, according to preliminary data from the CDC.

We explore how A.I. is transforming the way we work — for good and for bad.

Heart attack deaths spiked early in the pandemic, erasing years of progress in battling cardiovascular disease.

Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it.

The finding could lead to a better understanding of a condition that affects millions.

Many new first-year Penn Medicine students had never administered or carried Narcan nasal spray before attending the school’s third consecutive naloxone “boot camp.”

Some people are getting cut from the program for missing paperwork. Pennsylvanians have up to 90 days to file appeals with the county and state.

Experts say stigma about addiction and lack of training among physicians and other medical workers often limits use of these drugs.

A movement to allow these drugs to be used for treatment — of depression, PTSD, even addiction — is sweeping the nation.

Dozens of Delaware athletic trainers prepped for the new season of high school sports with a new training seminar to freshen their skills.

The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy.

This incident is believed to be a part of a larger cyberattack, which is affecting hospitals in a number of other states.